Avid Bioservices Inc (CDMO)

[BioBS2012]

Does anybody but me think that maybe there was some funny business going on towards the end of the year? What looks better, 57m revenues with about the same projected for 2018 or 67m revenues with a forecasted decline of about 30% to 47m in 2018?

I believe JDM1 alluded to financial gymnastics over the weekend. Looks like Lytle trying to smooth out those lumpy Qtrs.

Still buggers the question as to what they presented to NASDAQ to get a few days extension for the R/S